-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NIP-292 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NIP-292 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NIP-292 in Idiopathic Pulmonary Fibrosis Drug Details:NIP-292 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Lung Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Lung Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lenvatinib Mesylate in Lung Adenocarcinoma Drug Details: Lenvatinib mesylate (Lenvima /...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ADG-206 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ADG-206 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ADG-206 in Solid Tumor Drug Details: ADG-206 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ADR-002K in Ischemic Cardiomyopathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ADR-002K in Ischemic CardiomyopathyDrug Details:ADR-002K is under development for the treatment of ischemic cardiomyopathy. The drug...
-
Product Insights
Heim Pal NIP – Heim Pal Pediatric Emergency Block – Budapest
Equip yourself with the essential tools needed to make informed and profitable decisions with our Heim Pal NIP - Heim Pal Pediatric Emergency Block - Budapest report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Kia Nip / Thai Bun – Thai Boon Roong Twin Tower World Trade Center – Phnom Penh
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kia Nip / Thai Bun - Thai Boon Roong Twin Tower World Trade Center - Phnom Penh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NIP-292
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NIP-292 Drug Details NIP-292 is under development for the treatment of idiopathic pulmonary fibrosis....
-
Product Insights
Hotpack – Hotpack NIP Manufacturing Plant – Dubai
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hotpack - Hotpack NIP Manufacturing Plant - Dubai report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Factor XI or plasma thromboplastin antecedent triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. Inhibitors of factor XIa include protein Z-dependent protease inhibitor. The Coagulation Factor XI pipeline market research report provides comprehensive information on the Coagulation Factor XI targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atrial fibrillation pipeline market research report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Atrial Fibrillation and features dormant and...